Navigating Parenthood: Can Men Take Ozempic When Trying to Conceive?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

When men pursue weight loss through GLP-1 therapy like semaglutide, questions about fertility naturally arise—especially for those actively planning to start or expand their families. Research indicates that semaglutide does not damage sperm or impair male reproductive capacity, though individual health factors and medication timing deserve careful consideration before beginning treatment.

How Semaglutide Affects Male Fertility & Sperm Production

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that slows digestion and increases feelings of fullness—it does not directly interact with the hormonal pathways controlling testosterone or sperm development. Clinical trials spanning thousands of participants have not identified semaglutide as a cause of infertility, erectile dysfunction, or reduced sperm count in men. The medication targets appetite regulation and glucose metabolism in the brain and gut, leaving the testicular tissue and hormonal signaling responsible for reproductive health largely unaffected.

Weight loss itself often improves fertility outcomes in men by reducing insulin resistance, lowering inflammatory markers, and improving cardiovascular function—all factors linked to better sperm quality and sexual performance. Men carrying excess body fat frequently experience lower testosterone levels and reduced sperm motility, both of which can improve significantly once weight normalizes through effective GLP-1 therapy. For men trying to conceive, the metabolic benefits of semaglutide may actually create a more favorable environment for reproduction than untreated obesity.

Timing Semaglutide Therapy When Planning Pregnancy

Men do not face the same biological deadline as women when it comes to starting semaglutide before conception—sperm are continuously produced in a roughly 74-day cycle, meaning new, healthy sperm form throughout treatment. Stopping semaglutide weeks before attempting pregnancy is unnecessary from a fertility standpoint, as the medication does not accumulate in reproductive tissue or cause lasting changes to sperm genetics. If a man and his partner decide to pursue conception while he is on semaglutide, the medication can typically continue without interruption, though discussing this plan with his prescribing provider ensures alignment with overall family health goals.

Some men benefit from stabilizing their weight loss and establishing consistent dosing for several months before attempting pregnancy, as this allows metabolic markers to fully improve and demonstrates whether the treatment regimen is sustainable. The Precision Peptide Genetic Test from PlexusDx can identify individual variations in peptide pathways that influence how effectively semaglutide works, helping men optimize their dose and timeline before conception planning begins. Open communication with healthcare providers about fertility intentions ensures semaglutide therapy supports—rather than complicates—family planning.

Metabolic Health, Obesity, & Reproductive Outcomes in Men

Untreated obesity is a documented risk factor for male infertility, associated with reduced sperm concentration, decreased motility, and increased DNA fragmentation in sperm. Excess body weight elevates estrogen relative to testosterone, raises core body temperature in the scrotum (which impairs sperm production), and increases oxidative stress—all mechanisms that semaglutide-driven weight loss can reverse. Men who achieve even modest weight reductions through GLP-1 therapy often see improvements in sexual function, fertility markers, and overall reproductive health within 6 to 12 months.

Conditions frequently comorbid with obesity—including type 2 diabetes, sleep apnea, and cardiovascular disease—also negatively affect male fertility by reducing blood flow, increasing inflammation, and depleting antioxidant defenses in reproductive tissue. Semaglutide improves glucose control and cardiovascular function, addressing root causes of fertility problems rather than creating new ones. For men struggling with both weight and conception challenges, GLP-1 therapy represents an opportunity to simultaneously improve metabolic health and reproductive capacity.

Medication Interactions & Safety Considerations for Men Trying to Conceive

Semaglutide does not interact with fertility treatments, testosterone replacement therapy, or medications commonly used to support male reproductive health. Men taking other medications should disclose their full medication list to ensure semaglutide does not alter absorption or efficacy of other drugs—though direct reproductive toxicity is not a documented concern with GLP-1 agents. PlexusDx operates through licensed 503A compounding pharmacies, ensuring medication purity and quality that meet pharmaceutical standards across all 50 states.

Nausea, the most common side effect of semaglutide during dose escalation, may temporarily reduce appetite and energy—but these effects typically resolve within weeks and do not indicate harm to reproductive function. Men should maintain adequate nutrition and hydration during weight loss, as severe caloric restriction (even from effective appetite suppression) can theoretically stress reproductive hormones. Balancing semaglutide's appetite-reducing effects with intentional nutrient intake supports both sustainable weight loss and fertility readiness. PlexusDx's Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no insurance required, making fertility-safe weight loss accessible to men planning families across diverse financial situations.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Does semaglutide cause infertility or reduce sperm count in men?

No—semaglutide does not damage sperm production, reduce testosterone, or impair male fertility. Clinical evidence shows no increased infertility risk with GLP-1 therapy. Weight loss from semaglutide often improves sperm quality by reducing obesity-related reproductive stress.

Should men stop taking semaglutide before attempting to conceive?

Stopping semaglutide before conception is not medically necessary. Sperm are continuously produced in a 74-day cycle, so the medication does not cause lasting reproductive changes. Many men continue semaglutide during conception attempts with provider approval.

How does weight loss from semaglutide support male fertility?

Obesity reduces testosterone, impairs sperm motility, and increases scrotal temperature—all factors harming fertility. Semaglutide-driven weight loss reverses these mechanisms by normalizing hormone levels, improving blood flow, and reducing reproductive inflammation within months.

Can semaglutide be used alongside fertility treatments or testosterone therapy?

Yes—semaglutide does not interact with fertility medications, testosterone replacement, or male enhancement treatments. Men using these therapies can safely take semaglutide, though discussing full medication details with healthcare providers ensures safe, coordinated care.

How can PlexusDx's Precision Peptide Genetic Test help men planning pregnancy?

The Precision Peptide Genetic Test ($298) identifies genetic variations in peptide pathways that influence how your body responds to semaglutide. Understanding your genetic profile helps optimize dosing and timing before conception planning, ensuring effective, personalized weight loss therapy.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.